Stanford University

Legal wrangling slows Stanford researcher's quest for a cure

Joanna Wysocka/Stanford Universit

Hope for CIRM leukemia disease team

The clock is ticking on the 14 CIRM Disease Team projects issued last October, which are working under a four-year deadline to hit the clinic. The $20 million acute myeloid leukemia project headed up by Irv Weissman of Stanford University just reported some promising progress.

NIH halts intramural human embryonic stem cell research

The NIH has stopped all human embryonic stem cell research being conducted on its campus, in response to the August 23 injunction on all such research.

According to Science:

Stem cells treat life-threatening skin condition

This week researchers at the University of Minnesota published a paper showing that stem cells from the bone marrow can help kids with a blistering skin condition called epidermolysis bullosa. The disease is horrible. Lacking a protein to anchor skin in place, the children's blister at the slightest touch -- on their skin, in their throat, inside their eyelids, and anywhere else skin forms.

Mouse muscles mimic newt regeneration

A disclaimer: this work was not funded by CIRM, nor does it directly have to do with stem cell research. It is, however, extremely cool, and strikes close to home. I spent hours as an undergrad slicing off the limbs of newts and marveling as the tiny fingers and toes re-emerged on newly formed limbs. Now Helen Blau at Stanford University has for the first time replicated that magic in mammals.

The competition that isn't: Adult vs. embryonic stem cells

The past few days have sent the blogosphere -- especially the anti-embryonic stem cell blogosphere -- abuzz over a story by the Associated Press with the headline "Adult Stem Cell Research Far Ahead of Embryonic."

iPS and embryonic stem cells -- similar but not the same

Two papers in Nature publications have raised questions about whether reprogrammed adult cells, called iPS cells, are truly interchangeable with embryonic stem cells as many have been assuming. The papers found that iPS cells created from different adult tissues still bear some hallmarks of those starting blocks.

Muscle stem cells a step closer to treating muscular dystrophy

Stanford scientists have overcome one significant hurdle in developing a therapy for muscle-wasting diseases like muscular dystrophy. Until now, the muscle stem cells that stand at the ready to repair muscle damage couldn't be grown outside the safe confines of a muscle. Once uprooted from their home and transferred to a laboratory dish, they matured into less useful progenitor cells. That's a problem because once mature the cells no longer have the potential to be transplanted to repair muscle damaged by injury or disease.

CIRM grantee Joanna Wysocka wins Outstanding Young Investigator Award

Some happy news from this week's meeting of the International Society for Stem Cell Research held in San Francisco (co-sponsored by CIRM): CIRM grantee Joanna Wysocka won the organization's Outstanding Young Investigator Award, given out at a session on Thursday morning.

Pages

Subscribe to RSS - Stanford University

© 2013 California Institute for Regenerative Medicine